Loss of DEP-1 (Ptprj) promotes myeloproliferative disease in FLT3-ITD acute myeloid leukemia

• Anne Kresinsky,
• Reinhard Bauer,
• Tina M. Schnöder,
• Tobias Berg,
• Daria Meyer,
• Volker Ast,
• Rainer König,
• Hubert Serve,
• Florian H. Heidel,
• Frank-D. Böhmer,
• Jörg P. Müller

Affiliations

Anne Kresinsky

Institute of Molecular Cell Biology, Center for Molecular Biomedicine (CMB), Jena University Hospital

Reinhard Bauer

Institute of Molecular Cell Biology, Center for Molecular Biomedicine (CMB), Jena University Hospital

Tina M. Schnöder

Innere Medizin II, Hämatologie und Onkologie, Jena University Hospital;Leibniz Institute on Aging, Fritz-Lipmann-Institute (FLI), Jena

Tobias Berg

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt

Daria Meyer

Network modelling, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany

Volker Ast

Network modelling, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany

Rainer König

Network modelling, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany

Hubert Serve

Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt

Florian H. Heidel

Innere Medizin II, Hämatologie und Onkologie, Jena University Hospital;Leibniz Institute on Aging, Fritz-Lipmann-Institute (FLI), Jena

Frank-D. Böhmer

Institute of Molecular Cell Biology, Center for Molecular Biomedicine (CMB), Jena University Hospital

Jörg P. Müller

Institute of Molecular Cell Biology, Center for Molecular Biomedicine (CMB), Jena University Hospital